scispace - formally typeset
R

Robert M. Carney

Researcher at Washington University in St. Louis

Publications -  237
Citations -  27874

Robert M. Carney is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Depression (differential diagnoses) & Myocardial infarction. The author has an hindex of 74, co-authored 229 publications receiving 26154 citations. Previous affiliations of Robert M. Carney include Mount Sinai St. Luke's and Mount Sinai Roosevelt & Jewish Hospital.

Papers
More filters
Journal ArticleDOI

A Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart Failure

TL;DR: A nurse-directed, multidisciplinary intervention can improve quality of life and reduce hospital use and medical costs for elderly patients with congestive heart failure.
Journal ArticleDOI

Depression and poor glycemic control: a meta-analytic review of the literature.

TL;DR: Depression is associated with hyperglycemia in patients with type 1 or type 2 diabetes and additional studies are needed to establish the directional nature of this relationship and to determine the effects of depression treatment on glycemic control and the long-term course of diabetes.
Journal ArticleDOI

Mood disorders in the medically ill: scientific review and recommendations.

TL;DR: A growing body of evidence suggests that biological mechanisms underlie a bidirectional link between mood disorders and many medical illnesses and there is evidence to suggest that mood disorders affect the course of medical illnesses.
Journal ArticleDOI

Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations A Scientific Statement From the American Heart Association

TL;DR: Despite the heterogeneity of published studies included in this review, the preponderance of evidence supports the recommendation that the American Heart Association should elevate depression to the status of a risk factor for adverse medical outcomes in patients with acute coronary syndrome.